Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

March 01, 1984; Volume 25,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Aman, R A

    1. You have access
      Discrimination of three types of opioid binding sites in rat brain in vivo.
      J S Rosenbaum, N H Holford, M L Richards, R A Aman and W Sadée
      Molecular Pharmacology March 1984, 25 (2) 242-248;
  2. Angel, L M

    1. You have access
      Characterization of the selective inhibition of the delta subclass of opioid binding sites by alcohols.
      J M Hiller, L M Angel and E J Simon
      Molecular Pharmacology March 1984, 25 (2) 249-255;
  3. Armitage, I M

    1. You have access
      Nuclear magnetic resonance studies on the antibiotic avoparcin, Conformational properties in relation to antibacterial activity.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 275-280;
    2. You have access
      Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 281-286;

B

  1. Barovsky, K

    1. You have access
      Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
      K Barovsky, C Pedone and G Brooker
      Molecular Pharmacology March 1984, 25 (2) 256-260;
  2. Benkovic, S J

    1. You have access
      Inhibition of HKSV28 cell growth by 5,11-methenyl-tetrahydrohomofolate.
      L J Slieker and S J Benkovic
      Molecular Pharmacology March 1984, 25 (2) 294-302;
  3. Berger, S H

    1. You have access
      Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
      S H Berger and M T Hakala
      Molecular Pharmacology March 1984, 25 (2) 303-309;
  4. Brooker, G

    1. You have access
      Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
      K Barovsky, C Pedone and G Brooker
      Molecular Pharmacology March 1984, 25 (2) 256-260;
  5. Bull, H G

    1. You have access
      Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;
  6. Bushfield, M

    1. You have access
      Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium.
      A H Drummond, M Bushfield and C H Macphee
      Molecular Pharmacology March 1984, 25 (2) 201-208;

C

  1. Cascieri, M A

    1. You have access
      Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;
  2. Catterall, W A

    1. You have access
      Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by local anesthetics.
      S W Postma and W A Catterall
      Molecular Pharmacology March 1984, 25 (2) 219-227;
    2. You have access
      Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
      M Willow, E A Kuenzel and W A Catterall
      Molecular Pharmacology March 1984, 25 (2) 228-234;
  3. Conti-Tronconi, B M

    1. You have access
      Purification and characterization of a bungarotoxin polypeptide which blocks nicotinic receptor function in primary culture of adrenal chromaffin cells.
      L Saiani, H Kageyama, B M Conti-Tronconi and A Guidotti
      Molecular Pharmacology March 1984, 25 (2) 327-334;

D

  1. Dahlberg, W

    1. You have access
      Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
      D W Kufe, R Weichselbaum, E M Egan, W Dahlberg and R J Fram
      Molecular Pharmacology March 1984, 25 (2) 322-326;
  2. Drummond, A H

    1. You have access
      Thyrotropin-releasing hormone stimulates rapid breakdown of phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 4-phosphate in GH3 pituitary tumor cells.
      C H Macphee and A H Drummond
      Molecular Pharmacology March 1984, 25 (2) 193-200;
    2. You have access
      Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium.
      A H Drummond, M Bushfield and C H Macphee
      Molecular Pharmacology March 1984, 25 (2) 201-208;
  3. Dumont, J E

    1. You have access
      The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
      F Miot, C Erneux, J N Wells and J E Dumont
      Molecular Pharmacology March 1984, 25 (2) 261-266;

E

  1. Egan, E M

    1. You have access
      Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
      D W Kufe, R Weichselbaum, E M Egan, W Dahlberg and R J Fram
      Molecular Pharmacology March 1984, 25 (2) 322-326;
  2. Ellestad, G A

    1. You have access
      Nuclear magnetic resonance studies on the antibiotic avoparcin, Conformational properties in relation to antibacterial activity.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 275-280;
    2. You have access
      Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 281-286;
  3. Erneux, C

    1. You have access
      The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
      F Miot, C Erneux, J N Wells and J E Dumont
      Molecular Pharmacology March 1984, 25 (2) 261-266;

F

  1. Fesik, S W

    1. You have access
      Nuclear magnetic resonance studies on the antibiotic avoparcin, Conformational properties in relation to antibacterial activity.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 275-280;
    2. You have access
      Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 281-286;
  2. Fram, R J

    1. You have access
      Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
      D W Kufe, R Weichselbaum, E M Egan, W Dahlberg and R J Fram
      Molecular Pharmacology March 1984, 25 (2) 322-326;

G

  1. George, J W

    1. You have access
      Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.
      L R Pohl, R D Schulick, R J Highet and J W George
      Molecular Pharmacology March 1984, 25 (2) 318-321;
  2. Gould, R J

    1. You have access
      Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
      R J Gould, K M Murphy and S H Snyder
      Molecular Pharmacology March 1984, 25 (2) 235-241;
  3. Guidotti, A

    1. You have access
      Purification and characterization of a bungarotoxin polypeptide which blocks nicotinic receptor function in primary culture of adrenal chromaffin cells.
      L Saiani, H Kageyama, B M Conti-Tronconi and A Guidotti
      Molecular Pharmacology March 1984, 25 (2) 327-334;

H

  1. Hakala, M T

    1. You have access
      Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil.
      S H Berger and M T Hakala
      Molecular Pharmacology March 1984, 25 (2) 303-309;
  2. Highet, R J

    1. You have access
      Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.
      L R Pohl, R D Schulick, R J Highet and J W George
      Molecular Pharmacology March 1984, 25 (2) 318-321;
  3. Hiller, J M

    1. You have access
      Characterization of the selective inhibition of the delta subclass of opioid binding sites by alcohols.
      J M Hiller, L M Angel and E J Simon
      Molecular Pharmacology March 1984, 25 (2) 249-255;
  4. Holford, N H

    1. You have access
      Discrimination of three types of opioid binding sites in rat brain in vivo.
      J S Rosenbaum, N H Holford, M L Richards, R A Aman and W Sadée
      Molecular Pharmacology March 1984, 25 (2) 242-248;
  5. Hoyer, D

    1. You have access
      Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
      D Hoyer, E E Reynolds and P B Molinoff
      Molecular Pharmacology March 1984, 25 (2) 209-218;

K

  1. Kageyama, H

    1. You have access
      Purification and characterization of a bungarotoxin polypeptide which blocks nicotinic receptor function in primary culture of adrenal chromaffin cells.
      L Saiani, H Kageyama, B M Conti-Tronconi and A Guidotti
      Molecular Pharmacology March 1984, 25 (2) 327-334;
  2. Kuenzel, E A

    1. You have access
      Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
      M Willow, E A Kuenzel and W A Catterall
      Molecular Pharmacology March 1984, 25 (2) 228-234;
  3. Kufe, D W

    1. You have access
      Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
      D W Kufe, R Weichselbaum, E M Egan, W Dahlberg and R J Fram
      Molecular Pharmacology March 1984, 25 (2) 322-326;

L

  1. Langry, K C

    1. You have access
      The allylisopropylacetamide and novonal prosthetic heme adducts.
      P R Ortiz de Montellano, R A Stearns and K C Langry
      Molecular Pharmacology March 1984, 25 (2) 310-317;
  2. Liang, T

    1. You have access
      Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;

M

  1. Macphee, C H

    1. You have access
      Thyrotropin-releasing hormone stimulates rapid breakdown of phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 4-phosphate in GH3 pituitary tumor cells.
      C H Macphee and A H Drummond
      Molecular Pharmacology March 1984, 25 (2) 193-200;
    2. You have access
      Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium.
      A H Drummond, M Bushfield and C H Macphee
      Molecular Pharmacology March 1984, 25 (2) 201-208;
  2. McGahren, W J

    1. You have access
      Nuclear magnetic resonance studies on the antibiotic avoparcin, Conformational properties in relation to antibacterial activity.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 275-280;
    2. You have access
      Nuclear magnetic resonance studies on the interaction of avoparcin with model receptors of bacterial cell walls.
      S W Fesik, I M Armitage, G A Ellestad and W J McGahren
      Molecular Pharmacology March 1984, 25 (2) 281-286;
  3. Miot, F

    1. You have access
      The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
      F Miot, C Erneux, J N Wells and J E Dumont
      Molecular Pharmacology March 1984, 25 (2) 261-266;
  4. Molinoff, P B

    1. You have access
      Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
      D Hoyer, E E Reynolds and P B Molinoff
      Molecular Pharmacology March 1984, 25 (2) 209-218;
  5. Mumford, R A

    1. You have access
      Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;
  6. Murphy, K M

    1. You have access
      Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
      R J Gould, K M Murphy and S H Snyder
      Molecular Pharmacology March 1984, 25 (2) 235-241;

O

  1. Ortiz de Montellano, P R

    1. You have access
      The allylisopropylacetamide and novonal prosthetic heme adducts.
      P R Ortiz de Montellano, R A Stearns and K C Langry
      Molecular Pharmacology March 1984, 25 (2) 310-317;

P

  1. Patchett, A A

    1. You have access
      Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;
  2. Pedone, C

    1. You have access
      Distinct mechanisms of forskolin-stimulated cyclic AMP accumulation and forskolin-potentiated hormone responses in C6-2B cells.
      K Barovsky, C Pedone and G Brooker
      Molecular Pharmacology March 1984, 25 (2) 256-260;
  3. Pohl, L R

    1. You have access
      Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.
      L R Pohl, R D Schulick, R J Highet and J W George
      Molecular Pharmacology March 1984, 25 (2) 318-321;
  4. Postma, S W

    1. You have access
      Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by local anesthetics.
      S W Postma and W A Catterall
      Molecular Pharmacology March 1984, 25 (2) 219-227;

R

  1. Reynolds, E E

    1. You have access
      Agonist-induced changes in the properties of beta-adrenergic receptors on intact S49 lymphoma cells. Time-dependent changes in the affinity of the receptor for agonists.
      D Hoyer, E E Reynolds and P B Molinoff
      Molecular Pharmacology March 1984, 25 (2) 209-218;
  2. Richards, M L

    1. You have access
      Discrimination of three types of opioid binding sites in rat brain in vivo.
      J S Rosenbaum, N H Holford, M L Richards, R A Aman and W Sadée
      Molecular Pharmacology March 1984, 25 (2) 242-248;
  3. Rosenbaum, J S

    1. You have access
      Discrimination of three types of opioid binding sites in rat brain in vivo.
      J S Rosenbaum, N H Holford, M L Richards, R A Aman and W Sadée
      Molecular Pharmacology March 1984, 25 (2) 242-248;

S

  1. Sadée, W

    1. You have access
      Discrimination of three types of opioid binding sites in rat brain in vivo.
      J S Rosenbaum, N H Holford, M L Richards, R A Aman and W Sadée
      Molecular Pharmacology March 1984, 25 (2) 242-248;
  2. Saiani, L

    1. You have access
      Purification and characterization of a bungarotoxin polypeptide which blocks nicotinic receptor function in primary culture of adrenal chromaffin cells.
      L Saiani, H Kageyama, B M Conti-Tronconi and A Guidotti
      Molecular Pharmacology March 1984, 25 (2) 327-334;
  3. Schulick, R D

    1. You have access
      Reductive-oxygenation mechanism of metabolism of carbon tetrachloride to phosgene by cytochrome P-450.
      L R Pohl, R D Schulick, R J Highet and J W George
      Molecular Pharmacology March 1984, 25 (2) 318-321;
  4. Silver, P J

    1. You have access
      Phosphorylation of myosin light chain and phosphorylase in tracheal smooth muscle in response to KCl and carbachol.
      P J Silver and J T Stull
      Molecular Pharmacology March 1984, 25 (2) 267-274;
  5. Simon, E J

    1. You have access
      Characterization of the selective inhibition of the delta subclass of opioid binding sites by alcohols.
      J M Hiller, L M Angel and E J Simon
      Molecular Pharmacology March 1984, 25 (2) 249-255;
  6. Slieker, L J

    1. You have access
      Inhibition of HKSV28 cell growth by 5,11-methenyl-tetrahydrohomofolate.
      L J Slieker and S J Benkovic
      Molecular Pharmacology March 1984, 25 (2) 294-302;
  7. Snyder, S H

    1. You have access
      Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipine.
      R J Gould, K M Murphy and S H Snyder
      Molecular Pharmacology March 1984, 25 (2) 235-241;
  8. Stearns, R A

    1. You have access
      The allylisopropylacetamide and novonal prosthetic heme adducts.
      P R Ortiz de Montellano, R A Stearns and K C Langry
      Molecular Pharmacology March 1984, 25 (2) 310-317;
  9. Stull, J T

    1. You have access
      Phosphorylation of myosin light chain and phosphorylase in tracheal smooth muscle in response to KCl and carbachol.
      P J Silver and J T Stull
      Molecular Pharmacology March 1984, 25 (2) 267-274;

T

  1. Thornberry, N A

    1. You have access
      Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
      M A Cascieri, H G Bull, R A Mumford, A A Patchett, N A Thornberry and T Liang
      Molecular Pharmacology March 1984, 25 (2) 287-293;

W

  1. Weichselbaum, R

    1. You have access
      Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair.
      D W Kufe, R Weichselbaum, E M Egan, W Dahlberg and R J Fram
      Molecular Pharmacology March 1984, 25 (2) 322-326;
  2. Wells, J N

    1. You have access
      The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
      F Miot, C Erneux, J N Wells and J E Dumont
      Molecular Pharmacology March 1984, 25 (2) 261-266;
  3. Willow, M

    1. You have access
      Inhibition of voltage-sensitive sodium channels in neuroblastoma cells and synaptosomes by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
      M Willow, E A Kuenzel and W A Catterall
      Molecular Pharmacology March 1984, 25 (2) 228-234;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 25, Issue 2
1 Mar 1984
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics